Hana Levkovitz

1.5k total citations
24 papers, 1.2k citations indexed

About

Hana Levkovitz is a scholar working on Immunology, Molecular Biology and Surgery. According to data from OpenAlex, Hana Levkovitz has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Hana Levkovitz's work include Atherosclerosis and Cardiovascular Diseases (9 papers), Cholesterol and Lipid Metabolism (5 papers) and Magnesium in Health and Disease (4 papers). Hana Levkovitz is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (9 papers), Cholesterol and Lipid Metabolism (5 papers) and Magnesium in Health and Disease (4 papers). Hana Levkovitz collaborates with scholars based in Israel, Russia and United States. Hana Levkovitz's co-authors include Dror Harats, Aviv Shaish, Jacob George, Arnon Afek, Iris Goldberg, Boris Gilburd, Yehuda Shoenfeld, Hiroki Kurihara, Elliott Sigal and Mary A. Mulkins and has published in prestigious journals such as Circulation, PLoS ONE and Diabetes.

In The Last Decade

Hana Levkovitz

24 papers receiving 1.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Hana Levkovitz 555 372 221 199 192 24 1.2k
V.V. Tertov 856 1.5× 515 1.4× 561 2.5× 289 1.5× 134 0.7× 69 1.7k
Melba Hernandez 356 0.6× 429 1.2× 463 2.1× 197 1.0× 58 0.3× 15 1.2k
Charlotte Burton 370 0.7× 519 1.4× 501 2.3× 193 1.0× 61 0.3× 18 1.3k
Serge Monier 533 1.0× 771 2.1× 892 4.0× 170 0.9× 64 0.3× 32 1.7k
Vladimir V. Tertov 409 0.7× 239 0.6× 349 1.6× 139 0.7× 38 0.2× 34 897
Agostino Faggiotto 567 1.0× 288 0.8× 560 2.5× 244 1.2× 28 0.1× 12 1.5k
U P Steinbrecher 520 0.9× 384 1.0× 411 1.9× 128 0.6× 39 0.2× 9 1.4k
M K Offermann 410 0.7× 410 1.1× 124 0.6× 205 1.0× 23 0.1× 14 1.3k
Akemi Kakino 591 1.1× 473 1.3× 174 0.8× 141 0.7× 62 0.3× 35 1.2k
Ginette Bessède 308 0.6× 752 2.0× 733 3.3× 85 0.4× 53 0.3× 19 1.3k

Countries citing papers authored by Hana Levkovitz

Since Specialization
Citations

This map shows the geographic impact of Hana Levkovitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hana Levkovitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hana Levkovitz more than expected).

Fields of papers citing papers by Hana Levkovitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hana Levkovitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hana Levkovitz. The network helps show where Hana Levkovitz may publish in the future.

Co-authorship network of co-authors of Hana Levkovitz

This figure shows the co-authorship network connecting the top 25 collaborators of Hana Levkovitz. A scholar is included among the top collaborators of Hana Levkovitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hana Levkovitz. Hana Levkovitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boehm‐Cagan, Anat, Dror Harats, Aviv Shaish, et al.. (2016). Differential Effects of apoE4 and Activation of ABCA1 on Brain and Plasma Lipoproteins. PLoS ONE. 11(11). e0166195–e0166195. 26 indexed citations
2.
Gonen, Ayelet, Dror Harats, Aharon Rabinkov, et al.. (2005). The Antiatherogenic Effect of Allicin: Possible Mode of Action. Pathobiology. 72(6). 325–334. 81 indexed citations
3.
Levi, Zohar, Aviv Shaish, Niva Yacov, et al.. (2003). Rosiglitazone (PPARγ‐agonist) attenuates atherogenesis with no effect on hyperglycaemia in a combined diabetes–atherosclerosis mouse model. Diabetes Obesity and Metabolism. 5(1). 45–50. 64 indexed citations
4.
Cohen, Hofit, Yaniv Sherer, Aviv Shaish, et al.. (2002). Atherogenesis Inhibition Induced by Magnesium-Chloride Fortification of Drinking Water. Biological Trace Element Research. 90(1-3). 251–260. 15 indexed citations
5.
Shaish, Aviv, Gad Keren, Pierre Chouraqui, Hana Levkovitz, & Dror Harats. (2001). Imaging of Aortic Atherosclerotic Lesions by <sup>125</sup>I-LDL, <sup>125</sup>I-Oxidized-LDL, <sup>125</sup>I-HDL and <sup>125</sup>I-BSA. Pathobiology. 69(4). 225–229. 30 indexed citations
6.
Varda‐Bloom, Nira, Aviv Shaish, Ayelet Gonen, et al.. (2001). Tissue-specific gene therapy directed to tumor angiogenesis. Gene Therapy. 8(11). 819–827. 62 indexed citations
7.
Sharabi, Yehonatan, Ehud Grossman, Yaniv Sherer, et al.. (2000). The Effect of Renin-Angiotensin Axis Inhibition on Early Atherogenesis in LDL-Receptor-Deficient Mice. Pathobiology. 68(6). 270–274. 4 indexed citations
8.
Sherer, Yaniv, Yehuda Shoenfeld, Aviv Shaish, et al.. (2000). Suppression of Atherogenesis in Female Low-Density Lipoprotein Receptor Knockout Mice following Magnesium Fortification of Drinking Water: The Importance of Diet. Pathobiology. 68(2). 93–98. 17 indexed citations
9.
Shaish, Aviv, David Mirelman, Talia Miron, et al.. (2000). Allicin reduces atherosclerosis in mice and inhibits LDL Degradation in isolated mouse macrophages. Atherosclerosis. 151(1). 257–257. 2 indexed citations
10.
Varda‐Bloom, Nira, Aviv Shaish, Ayelet Gonen, Hana Levkovitz, & Dror Harats. (2000). The preproendothelin-1 promoter as a tool for specific gene therapy to angiogenic vascular endothelial cells. Atherosclerosis. 151(1). 101–102. 2 indexed citations
11.
12.
Sherer, Yaniv, Aviv Shaish, Hana Levkovitz, et al.. (1999). Magnesium Fortification of Drinking Water Suppresses Atherogenesis in Male LDL-Receptor-Deficient Mice. Pathobiology. 67(4). 207–213. 20 indexed citations
13.
Shaish, Aviv, Jacob George, Boris Gilburd, et al.. (1999). Dietary β-Carotene and α-Tocopherol Combination Does Not Inhibit Atherogenesis in an ApoE–Deficient Mouse Model. Arteriosclerosis Thrombosis and Vascular Biology. 19(6). 1470–1475. 52 indexed citations
14.
Shaish, Aviv, Yaniv Sherer, Hana Levkovitz, Yehuda Shoenfeld, & Dror Harats. (1999). Magnesium fortifecation of drinking water suppresses atherogenesis in male LDL-receptor knockout mice. Atherosclerosis. 144. 96–96. 1 indexed citations
15.
George, Jacob, Arnon Afek, Boris Gilburd, et al.. (1998). Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. Atherosclerosis. 138(1). 147–152. 207 indexed citations
16.
George, Jacob, Arnon Afek, Boris Gilburd, et al.. (1998). Induction of Early Atherosclerosis in LDL-Receptor–Deficient Mice Immunized With β 2 -Glycoprotein I. Circulation. 98(11). 1108–1115. 167 indexed citations
17.
Harats, Dror, Jacob George, Arnon Afek, et al.. (1997). 1.P.10 Hyperimmunization of chow-fed ApoE deficient mice with homologous oxidized low density lipoprotein suppresses early atherogenesis. Atherosclerosis. 134(1-2). 18–18. 5 indexed citations
18.
Sehayek, Ephraim, Israël Vlodavsky, Rachel Avner, et al.. (1996). Heparan sulfate-dependent and low density lipoprotein receptor-related protein-dependent catabolic pathways for lipoprotein lipase in mouse embryonic fibroblasts.. PubMed. 32(6). 449–54. 9 indexed citations
19.
Sehayek, Ephraim, Thomas Olivecrona, Gunilla Bengtsson-Olivecrona, et al.. (1995). Binding to heparan sulfate is a major event during catabolism of lipoprotein lipase by HepG2 and other cell cultures. Atherosclerosis. 114(1). 1–8. 16 indexed citations
20.
Sehayek, Ephraim, et al.. (1994). Enhanced cellular metabolism of very low density lipoprotein by simvastatin. A novel mechanism of action of HMG‐CoA reductase inhibitors. European Journal of Clinical Investigation. 24(3). 173–178. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by V.V. Tertov Breakdown of academic impact, for papers by Melba Hernandez Breakdown of academic impact, for papers by Charlotte Burton Breakdown of academic impact, for papers by Serge Monier Breakdown of academic impact, for papers by Vladimir V. Tertov Breakdown of academic impact, for papers by Agostino Faggiotto Breakdown of academic impact, for papers by U P Steinbrecher Breakdown of academic impact, for papers by M K Offermann Breakdown of academic impact, for papers by Akemi Kakino Breakdown of academic impact, for papers by Ginette Bessède
Rankless by CCL
2026